Literature DB >> 21266693

Nutrition support for the acute lung injury/adult respiratory distress syndrome patient: a review.

Krista L Turner1, Frederick A Moore, Robert Martindale.   

Abstract

Support for Acute Lung Injury (ALI) and Adult Respiratory Distress Syndrome (ARDS) in many ways represents the summation of all intensive care unit nutrition modalities. Basic tenets of management are based on those established for the general population of mechanically ventilated patients. As a marker of critical illness however, patients with ALI/ARDS suffer from other organ dysfunctions that require advanced support. Specific issues to be considered in this population include carbon dioxide production, prevention of aspiration, and modulation of the inflammatory response. These particular areas, with special attention paid to the role of lipids in ALI/ARDS, will be reviewed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266693     DOI: 10.1177/0884533610393255

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  4 in total

Review 1.  Acute respiratory distress syndrome.

Authors:  Ashley Mann; Gerald L Early
Journal:  Mo Med       Date:  2012 Sep-Oct

Review 2.  Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

Authors:  Martin D Rosenthal; Jayshil Patel; Kyle Staton; Robert G Martindale; Frederick A Moore; Gilbert R Upchurch
Journal:  Curr Gastroenterol Rep       Date:  2018-08-04

3.  ACG Clinical Guideline: Nutrition Therapy in the Adult Hospitalized Patient.

Authors:  Stephen A McClave; John K DiBaise; Gerard E Mullin; Robert G Martindale
Journal:  Am J Gastroenterol       Date:  2016-03-08       Impact factor: 10.864

4.  The effects and safety of omega-3 fatty for acute lung injury: a systematic review and meta-analysis.

Authors:  Zhongjie Huang; Jianming Zheng; Wencheng Huang; Meihao Yan; Liyue Hong; Yuancheng Hong; Runnv Jin; Xincheng Huang; Hongtao Fan; Huiling Chen; Heping Yang; Weiping Su; Xiaoping Huang
Journal:  World J Surg Oncol       Date:  2020-09-03       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.